Ausgabe 4/2021
Special Issue: Childhood cancer predisposition syndromes
Inhalt (14 Artikel)
Effective identification of cancer predisposition syndromes in children with cancer employing a questionnaire
Miriam Schwermer, Astrid Behnert, Beate Dörgeloh, Tim Ripperger, Christian P. Kratz
Clinical value of a screening tool for tumor predisposition syndromes in childhood cancer patients (TuPS): a prospective, observational, multi-center study
Floor A. M. Postema, Saskia M. J. Hopman, Corianne A. J. M. de Borgie, Cora M. Aalfs, Jakob K. Anninga, Lieke P. V. Berger, Fonnet E. Bleeker, Charlotte J. Dommering, Natasha K. A. van Eijkelenburg, Peter Hammond, Marry M. van den Heuvel-Eibrink, Janna A. Hol, Wijnanda A. Kors, Tom G. W. Letteboer, Jan L. C. M. Loeffen, Lisethe Meijer, Maran J. W. Olderode-Berends, Anja Wagner, Raoul C. Hennekam, Johannes H. M. Merks
Proportion of children with cancer that have an indication for genetic counseling and testing based on the cancer type irrespective of other features
Thi Minh Kha Nguyen, Astrid Behnert, Torsten Pietsch, Christian Vokuhl, Christian Peter Kratz
Selection criteria for assembling a pediatric cancer predisposition syndrome gene panel
Anna Byrjalsen, Illja J. Diets, Jette Bakhuizen, Thomas van Overeem Hansen, Kjeld Schmiegelow, Anne-Marie Gerdes, Ulrik Stoltze, Roland P. Kuiper, Johannes H. M. Merks, Karin Wadt, Marjolijn Jongmans
Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer
Tim Ripperger, D Gareth Evans, David Malkin, Christian P. Kratz
Correction to: Choose and stay on one out of two paths: distinction between clinical versus research genetic testing to identify cancer predisposition syndromes among patients with cancer
Tim Ripperger, D. Gareth Evans, David Malkin, Christian P. Kratz
Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies
Brigitte Schlegelberger, Cristina Mecucci, Marcin Wlodarski
Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group
M. C. Frühwald, K. Nemes, H. Boztug, M. C. A. Cornips, D. G. Evans, R. Farah, S. Glentis, M. Jorgensen, K. Katsibardi, S. Hirsch, K. Jahnukainen, I. Kventsel, K. Kerl, C. P. Kratz, K. W. Pajtler, U. Kordes, V. Ridola, E. Stutz, F. Bourdeaut
Current recommendations for cancer surveillance in Gorlin syndrome: a report from the SIOPE host genome working group (SIOPE HGWG)
L. Guerrini-Rousseau, M. J. Smith, C. P. Kratz, B. Doergeloh, S. Hirsch, S. M. J. Hopman, M. Jorgensen, M. Kuhlen, O. Michaeli, T. Milde, V. Ridola, A. Russo, H. Salvador, N. Waespe, B. Claret, L. Brugieres, D. G. Evans
Genetic testing and surveillance in infantile myofibromatosis: a report from the SIOPE Host Genome Working Group
Simone Hettmer, Guillaume Dachy, Guido Seitz, Abbas Agaimy, Catriona Duncan, Marjolijn Jongmans, Steffen Hirsch, Iris Kventsel, Uwe Kordes, Ronald R. de Krijger, Markus Metzler, Orli Michaeli, Karolina Nemes, Anna Poluha, Tim Ripperger, Alexandra Russo, Stephanie Smetsers, Monika Sparber-Sauer, Eveline Stutz, Franck Bourdeaut, Christian P. Kratz, Jean-Baptiste Demoulin
Surveillance recommendations for DICER1 pathogenic variant carriers: a report from the SIOPE Host Genome Working Group and CanGene-CanVar Clinical Guideline Working Group
Jette J. Bakhuizen, Helen Hanson, Karin van der Tuin, Fiona Lalloo, Marc Tischkowitz, Karin Wadt, Marjolijn C. J. Jongmans, Beate B. Dörgeloh, Roula A. Farah, Stavros Glentis, Lisa Golmard, Juliane Hoyer, Kirsi Jahnukainen, Rosalyn Jewell, Axel Karow, Katharina Katsibardi, Michaela Kuhlen, Andrea Meinhardt, Karolina Nemes, Anna Poluha, Tim Ripperger, Nicolas Waespe, Julian Adlard, Munaza Ahmed, Bernadette Brennan, Tabib Dabir, D. Gareth Evans, Anna Kelsey, Kelly Kohut, Anju Kulkarni, Alex Murray, Kai Ren Ong, Anthony Penn, Thomas Semple, Emma R. Woodward, Rachel S. van Leeuwaarde, Annemieke S. Littooij, Johannes H. M. Merks, Åse K. Rasmussen, Hanneke M. van Santen, Stephanie E. Smetsers
Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma
N. van Engelen, F. van Dijk, E. Waanders, A. Buijs, M. A. Vermeulen, J. L. C. Loeffen, R. P. Kuiper, M. C. J. Jongmans
Ovarian carcinoma in children with constitutional mutation of SMARCA4: single-family report and literature review
Agata Pastorczak, Karolina Krajewska, Zuzanna Urbanska, Bartosz Szmyd, Elzbieta Salacinska-Los, Józef Kobos, Wojciech Mlynarski, Joanna Trelinska
The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay
C. Kelaidi, V. Tzotzola, S. Polychronopoulou